NP Life Sciences Health Industry Group Inc.
Cash Flow Statement
| Line Item | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $-2.9K | $-18.9K | $-65.7K | $-131.1K | $-108.8K |
| Depreciation & Amortization | — | — | — | — | — |
| Depreciation | — | — | — | — | — |
| Amortization | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Net Cash from Operating Activities | $-73.6K | $93.9K | $-90.6K | $-124.3K | $-4.3K |
| Investing Activities | |||||
| Capital Expenditures | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | — | $-8.6K |
| Financing Activities | |||||
| Dividends Paid | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — |
| Net Cash from Financing Activities | $22.4K | — | — | — | $364.4K |
| Net Change in Cash | $-51.2K | $93.9K | $-90.6K | $-124.3K | $242.7K |
| Free Cash Flow | — | — | — | — | — |